Abiopharma

🔍 Genworth Holdings, Inc. (Executive)

Company: Enact Holdings, Inc. (ACT)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Sold 560,453 shares of Common Stock at $42.5521 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 112,809,079.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: The sale reported in this Form 4 was effected pursuant to a Share Repurchase Agreement between Enact Holdings, Inc. (the "Issuer") and Genworth Holdings, Inc. dated as of February 2, 2026 (the "Agreement"). A copy of the Agreement can be found as exhibit 99.4 to the Issuer's Form 8-K filed on February 3, 2026, on the SEC's website at: https://www.sec.gov/Archives/edgar/data/1823529/000182352926000003/february2026genworthenacts.htm
• F2: Represents a price per share determined pursuant to the terms of the Agreement, based on a weighted average price paid by the Issuer for purchases from third-parties.
• F3: Genworth Holdings, Inc. owns approximately 81% of the outstanding shares of common stock of the Issuer.